Prelude Capital Management, LLC Heron Therapeutics, Inc. Transaction History

Prelude Capital Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $47,379 - $129,574	-20,600 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $95,378 - $204,764	20,600 New	20,600 $118,000
Q3 2020 Nov 16, 2020	SELL	$13.67 - $17.77 $275,395 - $357,994	-20,146 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$10.89 - $21.47 $216,188 - $426,222	19,852 Added 6752.38%	20,146 $296,000
Q4 2019 Feb 14, 2020	BUY	$17.42 - $26.61 $5,121 - $7,823	294 New	294 $7,000
Q3 2019 Nov 14, 2019	SELL	$16.36 - $21.39 $1,979 - $2,588	-121 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $151,184 - $234,144	-8,930 Reduced 98.66%	121 $2,000
Q1 2019 May 15, 2019	BUY	$23.15 - $28.34 $209,530 - $256,505	9,051 New	9,051 $221,000
Q4 2018 Feb 14, 2019	SELL	$22.03 - $32.01 $550,441 - $799,801	-24,986 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$30.0 - $40.85 $262,860 - $357,927	-8,762 Reduced 25.96%	24,986 $791,000
Q2 2018 Aug 14, 2018	SELL	$26.4 - $42.0 $189,076 - $300,804	-7,162 Reduced 17.51%	33,748 $1.31 Million
Q1 2018 May 15, 2018	SELL	$18.43 - $28.8 $207,392 - $324,086	-11,253 Reduced 21.57%	40,910 $1.13 Million
Q4 2017 Feb 14, 2018	BUY	$14.8 - $18.85 $208,976 - $266,162	14,120 Added 37.12%	52,163 $944,000
Q3 2017 Nov 14, 2017	BUY	$14.65 - $16.85 $557,329 - $641,024	38,043	38,043 $614,000

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.